CClinicalTrials.gg
RecruitingNCT07401186Updated Jun 4, 2026

Stimulation-Based Modulation of Spinal and Cortical Sensory Pathways

An interventional study of Bipolar Neural Stimulation Electrode in Stroke and Able Bodied, sponsored by Peter C. Gerszten, MD. Recruiting at 1 site in United States. Open to participants aged 21 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-04.

Sponsored by Peter C. Gerszten, MD · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
21 Years to 75 Years
Sex
All
01

Study summary

The goal of this study is to assess cervical (neck) reflexes by intra-operatively stimulating the neck nerve roots to evoke motor responses through their connections to spinal motoneurons. This data is critical to reveal changes to the spinal sensory modulating circuitry in neurological disorders like stroke.

Read the detailed description

Spinal afferents continuously convey sensory information on limb movements to the central nervous system which not only gives people conscious experience of movement, but also plays a major role in shaping motor output through monosynaptic afferent-motoneuronal connections. Stroke induces changes in the spinal circuitry modulating this sensory input, leading to sensorimotor deficits.

Specifically, the investigators will 1) activate the dorsal root fibers with single and double electrical stimulation pulses at various frequencies using FDA-cleared devices, 2) quantify the stimulation evoked motor potentials in arm and hand muscles recorded with intramuscular EMGs, 3) quantify stimulation evoked sensory potentials in the cortex with intra-op EEGs.

02

Conditions studied

  • Stroke
  • Able Bodied

Keywords

  • Central Nervous System Disease
  • Cerebrovascular Disorder
  • Brain Injury
  • Brain Disease
  • Movement Disorder
  • Nervous System
  • Stroke
  • Spinal Cord Disease
  • Nervous System Disease
  • Sensorimotor Disorder
03

Who can participate

Ages eligible
21 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • All Subjects: Ages between 21 and 75 years. The minimum age is selected to age match control subjects with stroke subjects. In addition, participants outside this age range may be at an increased medical risk.
  • Control subjects: Patients undergoing elective posterior cervical spinal surgery that includes a decompressive laminectomy, and who will have electrophysiological monitoring performed as part of the standard of care for their procedure.
  • Stroke subjects: Participants must have a suffered a single, ischemic or hemorrhagic stroke more than 6 months prior to the time of enrollment with hemiparesis as a result, is undergoing a cervical epidural lead implant or undergoing elective posterior cervical spinal surgery that includes a decompressive laminectomy with electrophysiological monitoring performed as part of the standard of care.

Exclusion criteria

Exclusion Criteria:

  • Patients will be excluded from the study if they have any known neurological diseases other than stroke, such as amyotrophic lateral sclerosis, spinal muscular atrophy, spinal cord injury, autoimmune neuropathy, or sensory nerve disorders, that may affect the integrity of cervical sensory afferents.
  • Only patients that are eligible for surgery will be enrolled. Therefore this automatically include as exclusion criteria: pregnancy and other clinical conditions eligible for surgery.
  • Participants must not be on anti-spasticity or anti-epileptic medications.
04

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Dorsal Spinal Nerve Root Stimulation

    Individuals undergoing cervical spinal surgery will receive direct electrical stimulation to the cervical dorsal spinal nerve roots.

    Device: Bipolar Neural Stimulation Electrode

Interventions

  • DeviceBipolar Neural Stimulation Electrode

    All individuals enrolled in this study will receive electrical stimulation to the dorsal cervical spinal nerves using the FDA-cleared bipolar stimulating electrode routinely used as standard-of-care to monitor neural function, during which muscle activities will be recorded through intramuscular electromyography (EMGs), and sensory evoked cortical local field potentials (SSEPs) will be acquired simultaneously to characterize properties of the spinal sensory pathways.

05

What researchers measure

Primary outcomes

  1. Spinal Circuit Excitability

    The investigators will record intramuscular electromyogram (EMG) of the hand and arm muscles evoked by dorsal nerve root stimulation at various frequencies to quantify spinal circuit excitability through the H-reflex. A mean difference of 10% from the baseline (first pulse per frequency) muscle activation will be considered a meaningful change in excitability.

    Time frame: 1 day

Secondary outcomes

  1. Sensory Transmission to the Brain

    The investigators will use electroencephalograph (EEG) to record sensory stimulation evoked potentials (SSEP) from the brain during dorsal root stimulation at various frequencies to quantify sensory transmission efficiency. A mean difference of 10% from the baseline (first pulse per frequency) SSEP will be considered a meaningful change.

    Time frame: 1 day

06

Study locations

1 of 1 sites recruiting
  • University of Pittsburgh
    Pittsburgh, Pennsylvania 15213, United States
    • Peter C Gerszten, MD · Contact · gersztenpc@upmc.edu · 412-647-0958
    • Sydney Bader · Contact · 412-648-4196
    • Peter C Gerszten, MD · Principal investigator
    Recruiting
07

References and documents

Individual participant data

Plan to share: Yes — All of the individual participant data collected during the trial, after deidentification, may be shared with other researchers for the purpose of data analysis and collaboration.

Supporting information: Study protocol, Sap, Icf, Csr, Analytic code

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07401186
Lead sponsor
Peter C. Gerszten, MD
Responsible party
Peter C. Gerszten, MD (Professor, University of Pittsburgh) — Sponsor-investigator
First posted
Feb 10, 2026
Start date
May 26, 2026
Primary completion
Aug 2027 (estimated)
Completion
Jan 2028 (estimated)
Last update
Jun 4, 2026

Study contacts

Peter C Gerszten, MD
Contact
gerspc@upmc.edu
412-647-0958
Elvira Pirondini, PhD
Contact
elvirap@pitt.edu
412-636-0595
Peter C Gerszten, MD
principal investigator · University of Pittsburgh, Neurological Surgery

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion